Cultural Meaning and the Experience of Hormone Drug Use Among Transgender Women Undergraduate Students in Southern Thailand

Main Article Content

Tida Sottiyotin
Pacharapol Apinuntachart
Yanisa Amornlak
Tidarat Muenlamai
Najmee Adulyarat


The practice of feminizing hormone drug use among transgender women is established but not well understood. This study used an interpretive phenomenological approach to explore the significance and experiences of hormone drug use among transgender women (TGW) undergraduate students. The study involved twenty-one participants in semi-structured interviews and applied thematic analysis to the data. Findings reveal that participants view hormone drug use as crucial for personal satisfaction and social acceptance. Their use of these drugs varied, including changes in medication type, dosage adjustments, and intermittent or consistent use, tailored over time to individual needs. These variations were influenced by factors encouraging or discouraging hormone drug use and by perceptions of recent hormone drug use, whether positive or negative. The study highlights the essential role of hormone drug use in transgender individuals' lives, emphasizing the need for greater attention and support in social and healthcare systems. It points to the importance of responsible use of feminizing hormones, addressing the unique needs of transgender women, and promoting a health and well-being supportive environment.

Article Details

How to Cite
Sottiyotin, T. ., Apinuntachart, P. ., Amornlak, Y. ., Muenlamai, T. ., & Adulyarat, N. (2024). Cultural Meaning and the Experience of Hormone Drug Use Among Transgender Women Undergraduate Students in Southern Thailand. Journal of Population and Social Studies [JPSS], 32, 515–530. Retrieved from
Research Articles
Author Biography

Najmee Adulyarat, Department of Social Administrative Pharmacy, School of Pharmacy, Walailak University, Thailand

Corresponding author


• Abraham, J. (2010). Pharmaceuticalization of society in context: Theoretical, empirical and health dimensions. Sociology, 44(4), 603–622.

• Augustaitis, L., Merrill, L., Gamarel, K. E., & Haimson, O. L. (2021). Online transgender health information seeking: Facilitators, barriers, and future directions. CHI ’21: Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems, Article 205.

• Bell, S. E., & Figert, A. E. (2012). Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways, and forward. Social Science & Medicine, 75(5), 775–783.

• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.

• Byne, W., Karasic, D. H., Coleman, E., Eyler, A. E., Kidd, J. D., Meyer-Bahlburg, H. F. L., Pleak, R. R., & Pula, J. (2018). Gender dysphoria in adults: An overview and primer for psychiatrists. Transgender Health, 3(1), 57–70.

• Chen, D., Kolbuck, V. D., Sutter, M., Tishelman, A. C., Quinn, G. P., & Nahata, L. (2019). Knowledge, practice behaviors, and perceived barriers to fertility care among providers of transgender healthcare. Journal of Adolescent Health, 64(2), 226–234.

• Clark, H., Babu, A. S., Wiewel, E. W., Opoku, J., & Crepaz, N. (2017). Diagnosed HIV infection in transgender adults and adolescents: Results from the National HIV Surveillance System, 2009–2014. AIDS and Behavior, 21(9), 2774–2783.

• Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders (1st ed.). Johns Hopkins University Press.

• Cooley, C. H. (2006). Looking-Glass Self. In J. O’Brien (Ed.), The production of reality: Essays and readings on social interaction (4th ed., pp. 255–256). Pine Forge Press.

• Creswell, J. W., & Poth, C. N. (2016). Qualitative inquiry and research design: Choosing among five approaches. Sage Publications.

• Denzin, N. K., & Lincoln, Y. S. (2017). The Sage Handbook of Qualitative Research (5th ed.). Sage Publications.

• Farber, R. (2023). Discrimination, health, and resistance for Thai transgender women. Journal of Racial and Ethnic Health Disparities.

• Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013). Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology, 13(1), Article 117.

• Goldwire, M. A., Johnson, S. T., Abdalla, M., Advani, A., Bernknopf, A., Colella, A., Kehr, H. A., Kier, K. L., May, D. B., May, J. R., Picone, M. F., Saad, M., Thornby, K. A., & Ward, K. E. (2023). Medical misinformation: A primer and recommendations for pharmacists. JACCP: Journal of the American College of Clinical Pharmacy, 6(5), 497–511.

• Gooren, L., Sungkaew, T., Giltay, E. J., & Guadamuz, T. E. (2014). Cross-sex hormone use, functional health and mental well-being among transgender men (Toms) and Transgender Women (Kathoeys) in Thailand. Culture, Health & Sexuality, 17(1), 92–103.

• Gordon, A. R., Austin, S. B., Krieger, N., Hughto, J. M. W., & Reisner, S. L. (2016). “I have to constantly prove to myself, to people, that I fit the bill”: Perspectives on weight and shape control behaviors among low-income, ethnically diverse young transgender women. Social Science & Medicine, 165, 141–149.

• Harper, J., O’Donnell, E., Khorashad, B. S., McDermott, H., & Witcomb, G. L. (2021). How does hormone transition in transgender women change body composition, muscle strength and haemoglobin? Systematic review with a focus on the implications for sport participation. British Journal of Sports Medicine, 55(15), 865–872.

• Jarernpanit, T., Ma, Q., & Wang, Y. (2019). The gender issues and identities of the young tomboy and lesbian in Chiang Mai and Phitsanulok of Thailand. Life Sciences and Environment Journal, 20(1), 172–184.

• Kaczmarek, E. (2019). How to distinguish medicalization from over-medicalization? Medicine, Health Care and Philosophy, 22(1), 119–128.

• Koch, J. M., Chris, C., McLachlan, T., Victor, C. J., Westcott, J., & Yager, C. (2019). The cost of being transgender: Where socio-economic status, global health care systems, and gender identity intersect. Psychology and Sexuality, 11(1–2), 103–119.

• Koch T. (1995). Interpretive approaches in nursing research: The influence of Husserl and Heidegger. Journal of Advanced Nursing, 21(5), 827–836.

• LaCaille, L. (2013). Theory of reasoned action. In M. D. Gellman & J. R. Turner (Eds.), Encyclopedia of Behavioral Medicine(pp. 1964–1967). Springer.

• Matua, G. A., & Van Der Wal, D. M. (2015). Differentiating between descriptive and interpretive phenomenological research approaches. Nurse researcher, 22(6), 22–27.

• Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., Lonardo, A., Maki, P. M., McCullough, L. D., Regitz-Zagrosek, V., Regensteiner, J. G., Rubin, J. B., Sandberg, K., & Suzuki, A. (2020). Sex and gender: Modifiers of health, disease, and medicine. The Lancet, 396(10250), 565–582.

• Meneu, R. (2018). Life medicalization and the recent appearance of “pharmaceuticalization.” Farmacia Hospitalaria, 42(4), 174–179.

• Ministry of Public Health [Thailand]. (2022). HIV Info Hub. Division of AIDS and STIs, Department of Disease Control, Ministry of Public Health, Thailand. Retrieved April 25, 2022, from

• Mohamed, S., & Hunter, M. (2018). Transgender women’s experiences and beliefs about hormone therapy through and beyond mid-age: An exploratory UK study. International Journal of Transgenderism, 20(1), 98–107.

• Newcomb, M. E., Hill, R., Buehler, K., Ryan, D. T., Whitton, S. W., & Mustanski, B. (2020). High burden of mental health problems, substance use, violence, and related psychosocial factors in transgender, non-binary, and gender diverse youth and young adults. Archives of Sexual Behavior, 49(2), 645–659.

• Nichter, M., & Vuckovic, N. (1994). Agenda for an anthropology of pharmaceutical practice. Social Science & Medicine (1982), 39(11), 1509–1525.

• O’Brien, B. C., Harris, I. B., Beckman, T. J., Reed, D. A., & Cook, D. A. (2014). Standards for reporting qualitative research: A synthesis of recommendations. Academic Medicine, 89(9), 1245–1251.

• Ojanen, T. T. (2009). Sexual/gender minorities in Thailand: Identities, challenges, and voluntary-sector counseling. Sexuality Research and Social Policy, 6(2), 4–34.

• Peat, G., Rodriguez, A., & Smith, J. (2019). Interpretive phenomenological analysis applied to healthcare research. Evidence-Based Nursing, 22(1), 7–9.

• Podhisita, C. (2021). วิทยาศาสตร์และศิลปะการวิจัยเชิงคุณภาพ [Science and art of qualitative research] (8th ed.). Amarin Printing & Publishing Public.

• Poompruek, P., Boonmongkon, P., & Guadamuz, T. E. (2014). ‘For me. . . it’s a miracle’: Injecting beauty among kathoeis in a provincial Thai city. International Journal of Drug Policy, 25(4), 798–803.

• Prasertsuk, S., & Wattananamkul, V. (2011). Drug use in social and cultural dimension of urban community. Isan Journal of Pharmaceutical Sciences, 7(1), 52–61.

• Regmi, P. R., van Teijlingen, E., Neupane, S. R., & Marahatta, S. B. (2019). Hormone use among Nepali transgender women: A qualitative study. BMJ Open, 9(10), Article e030464.

• Roberts, C. M., Klein, D. A., Adirim, T. A., Schvey, N. A., & Hisle-Gorman, E. (2022). Continuation of gender-affirming hormones among transgender adolescents and adults. The Journal of Clinical Endocrinology and Metabolism, 107(9), e3937–e3943.

• Samakkeekarom, R., Ratlerdkarn, S., Sinchai, K., Jullawat, K., Sangnak, N., & Taesombat, J. (2019). The use of hormone therapy among trans-woman students in government and private university. Quality of Life and Law Journal, 15(1), 48–66.

• Sottiyotin, T., Pradabmook-Sherer P., Sringernyuang L., & Boonmongkon P. (2020). A pill is not only a pill: The social meaning of the elderly’s daily medications. International Journal of Innovation, Creativity and Change, 11(7), 16–33.

• Srikummoon, P., Thanutan, Y., Manojai, N., Prasitwattanaseree, S., Boonyapisomparn, N., Kummaraka, U., Pateekhum, C., Chiawkhun P., Owatsakul C., Maneeton B., Maneeton N., Kawilapat S., & Traisathit S. (2022). Discrimination against and associated stigma experienced by transgender women with intersectional identities in Thailand. International Journal of Environmental Research and Public Health, 19(24), Article 16532.

• Sringernyuang, L., & Sottiyotin, T. (2022). “Ya Luk Ka Tan Yoo”: An ethnography of filial piety culture, medication usage, and health perceptions of the elderly in rural southern Thailand. International Journal of Environmental Research and Public Health, 19(19), Article 12134.

• Suriyasarn, B. (2014). Gender identity and sexual orientation in Thailand: Promoting Rights, Diversity and Equality in the World of Work (PRIDE) Project. International Labour Organization.

• Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357.

• United Nations Development Programme (UNDP). (2015). Blueprint for the provision of comprehensive care for trans people and trans communities in Asia and the Pacific. Health Policy Project, Asia Pacific Transgender Network, United Nations Development Programme.

• Vacharathit, V., Ratanalert, W., & Samitpol, K. (Eds.). (2021). The Thai Handbook of Transgender Healthcare Services. Center of Excellence in Transgender Health, Chulalongkorn University.

• Wirtz, A. L., Poteat, T. C., Malik, M., & Glass, N. (2020). Gender-based violence against transgender people in the United States: A call for research and programming. Trauma, Violence & Abuse, 21(2), 227–241.

• World Bank Group. (2018, March 1). Economic inclusion of LGBTI groups in Thailand (Vol. 2): Main report.

• Yan, Z.-H., Lin, J., Xiao, W.-J., Lin, K.-M., McFarland, W., Yan, H.-J., & Wilson, E. (2019). Identity, stigma, and HIV risk among transgender women: A qualitative study in Jiangsu Province, China. Infectious Diseases of Poverty, 8(1), Article 94.